Non-Small Cell Lung Cancer - Pipeline Review, H2 2016 - New Market Report
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer - Pipeline Review, H2 2016, provides an overview of the Non-Small Cell Lung Cancer (Oncology) pipeline landscape.
View full press release